PE Tech Report


Like this article?

Sign up to our free newsletter

Aptuit names Jonathan Goldman as CEO

Private equity-backed Aptuit has appointed Jonathan Goldman as chief executive officer, completing the company's senior management leadership team.

Goldman will focus his efforts on the growth of Aptuit as a provider of outsourced services in the early development space by establishing new partnerships with clients and pursuing strategic acquisitions.
He joins the company after achieving success at ICON Clinical Research, a contract research organisation that specialises in the provision of clinical and other solutions that support Phase I-IV clinical studies.
Goldman says: "I'm delighted to join Aptuit, and look forward to working closely with the entire team to leverage an outstanding value proposition that is unique in our industry. Pharma has an unmet need for lower cost, increased speed and better quality in drug discovery and development. Aptuit is the ideal partner to meet these needs across a comprehensive suite of services, supported by an approach that is both scientific and innovative. I look forward to continued growth of the company as the partner of choice for drug developers."
At ICON, Goldman was most recently executive vice president, global strategic and business development and a member of the senior leadership team. His accomplishments included record growth levels of sales, and the development of transformative business relationships with leading pharmaceutical and biotechnology companies. Previously, his roles at ICON included executive vice president, operations, strategic programmes and chief medical officer, ICON Medical Imaging.
Before joining ICON, Goldman served for seven years as the chief medical officer of POINT Biomedical, a US-based biopharmaceutical company that discovered and developed microsphere technologies and drugs. In addition, he has held honorary academic positions of increasing responsibility at the University of California since 2000, most recently as associate clinical professor of medicine in the division of cardiology.
Timothy C Tyson, chairman of Aptuit, says: "We're enthusiastic that Jonathan is joining us. He brings exceptional experience in science, sales and medicine, along with the innate talents that are needed to advance us to the next level of growth and accomplishments. His collaborative approach to understanding and satisfying the unmet needs of our clients makes him the perfect complement to our senior management team."

Like this article? Sign up to our free newsletter